pathogens of this required nutrient.4 While siderocalin tightly
binds a number of small-molecule phenolate siderophores such
as carboxymycobactins, enterochelin, and parabactin, it does
not bind to pyochelin. We have proposed that the presence of
a sterically demanding sulfur-containing thiazoline ring, which
replaces the oxazoline ring present in the other phenolate
siderophores, interferes with a conserved water-mediated hy-
drogen bond between these siderophores and siderocalin.4c,d In
contrast, pyochelin does bind to chicken Ex-FABP, a protein
with high sequence homology to human siderocalin in the
binding calyx region.5 The fact that chicken Ex-FABP also
shows affinity for a variable spectrum of microbial siderophores
raises the possibility that these proteins are part of an antibacte-
rial defense strategy employed across the phylum.
Synthesis of Carbapyochelins via
Diastereoselective Azidation of
5-(Ethoxycarbonyl)methylproline Derivatives
Wathsala Liyanage,† Laksiri Weerasinghe,†
Roland K. Strong,‡ and Juan R. Del Valle*,†
Department of Chemistry and Biochemistry, New Mexico
State UniVersity, MSC3C, Las Cruces, New Mexico 88003,
and DiVision of Basic Sciences, Fred Hutchinson Cancer
Research Center, MS A3-025, Seattle, Washington 98109
ReceiVed June 21, 2008
Two configurationally stable carbon-based analogues of
pyochelin have been prepared from Boc-pyroglutamic acid-
tert-butyl ester in 11 and 13 steps. Introduction of the amino
group was achieved by a highly diastereoselective electro-
philic azidation reaction to afford novel bis-R-amino acid
proline derivatives.
FIGURE 1. Pyochelin and configurationally stable proline-based
analogues.
To parse the ligand recognition parameters of both siderocalin
and chicken Ex-FABP, we sought to design and synthesize
analogues of pyochelin that would demonstrate both protein and
iron binding capabilities. Because pyochelin undergoes epimer-
ization at the 2′′ position through the general mechanism shown
in Figure 1, efforts to synthesize and isolate 1 in diastereomeri-
cally pure form have met with limited success.6 We envisioned
this problem could be circumvented by incorporating a meth-
ylene unit in place of the ring A sulfur, a position with no
established role in iron or siderocalin binding. In addition, we
sought to target the oxazoline variant 3 to test our steric clash
hypothesis through the design of an oxo analogue. These
analogues would potentially provide useful information on the
discreet stereochemical requirements for siderophore specific
protein-ligand interactions. Here, we describe our efforts toward
novel proline-based siderophores, resulting in a diastereoselec-
tive synthesis of amino acids 2 and 3.
Pyochelin (1) is a phenolate siderophore isolated from
Pseudomonas aeruginosa that enhances microbial growth by
solublizing ferric iron and accelerating iron transport.1 Studies
on P. aeruginosa iron uptake systems have focused largely on
the recognition of pyochelin by bacterial outer membrane
receptors.2 These efforts have benefited from the synthesis and
evaluation of various pyochelin analogues, many of which
chelate and transport iron(III) with similar efficiency compared
to the natural product.3
Recently, it has been shown that the endogenous protein
siderocalin (also lipocalin 2, NGAL) is able to bind and
sequester iron as complexes with siderophores, thus starving
† New Mexico State University.
‡ Fred Hutchinson Cancer Research Center.
(1) (a) Cox, C. D.; Graham, R. J. Bacteriol. 1979, 137, 357. (b) Cox, C. D.;
Rinehart, K. L., Jr.; Moore, M. L.; Cook, J. C., Jr Proc. Natl. Acad. Sci. U.S.A.
1981, 78, 4256. (c) Raymond, K. N.; Mu¨ller, G.; Matzanke, B. F. In Topics in
Current Chemistry; Boschke, F. L., Ed.; Springer-Verlag: Berlin, Germany, 1984;
Vol. 123, p 50.
(2) (a) Pattus, F.; Abdallah, M. A. J. Chin. Chem. Soc. 2000, 47, 1. (b) Poole,
K.; McKay, G. A. Front. Biosci. 2003, 8, D661.
(3) (a) Ankenbauer, R. G.; Staley, A. L.; Rinehart, K. L.; Cox, C. D. Proc.
Nat. Acad. Sci. U.S.A. 1991, 88, 1878. (b) Mislin, G. L.; Burger, A.; Abdallah,
M. A. Tetrahedron 2004, 60, 12139. (c) Rivault, F.; Liebert, C.; Burger, A.;
Hoegy, F.; Abdallah, M. A.; Schalk, I. J.; Mislin, G. L. A. Bioorg. Med. Chem.
Lett. 2007, 17, 640. (d) Rivault, F.; Liebert, C.; Burger, A.; Hoegy, F.; Abdallah
Mohamed, A.; Schalk Isabelle, J.; Mislin Gaetan, L. A. Bioorg. Med. Chem.
Lett. 2007, 17, 640. (e) Rivault, F.; Schons, V.; Liebert, C.; Burger, A.; Sakr,
E.; Abdallah, M. A.; Schalk, I. J.; Mislin, G. L. A. Tetrahedron 2006, 62, 2247.
(f) Zamri, A.; Schalk, I. J.; Pattus, F.; Abdallah, M. A. Bioorg. Med. Chem.
Lett. 2003, 13, 1147.
(4) (a) Fischbach, M. A.; Lin, H.; Zhou, L.; Yu, Y.; Abergel, R. J.; Liu,
D. R.; Raymond, K. N.; Wanner, B. L.; Strong, R. K.; Walsh, C. T.; Aderem,
A.; Smith, K. D. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 16502. (b) Flo, T. H.;
Smith, K. D.; Sato, S.; Rodriguez, D. J.; Holmes, M. A.; Strong, R. K.; Akira,
S.; Aderem, A. Nature 2004, 432, 917. (c) Goetz, D. H.; Holmes, M. A.;
Borregaard, N.; Bluhm, M. E.; Raymond, K. N.; Strong, R. K. Mol. Cell 2002,
10, 1033. (d) Holmes, M. A.; Paulsene, W.; Jide, X.; Ratledge, C.; Strong, R. K.
Structure 2005, 13, 29. (e) Yang, J.; Goetz, D.; Li, J. Y.; Wang, W.; Mori, K.;
Setlik, D.; Du, T.; Erdjument-Bromage, H.; Tempst, P.; Strong, R.; Barasch, J.
Mol. Cell 2002, 10, 1045.
(5) Descalzi Cancedda, F.; Dozin, B.; Zerega, B.; Cermelli, S.; Cancedda,
R. Biochim. Biophys. Acta 2000, 1482, 127.
(6) (a) Rinehart, K. L.; Staley, A. L.; Wilson, S. R.; Ankenbauer, R. G.;
Cox, C. D. J. Org. Chem. 1995, 60, 2786. (b) Zamri, A.; Abdallah, M. A.
Tetrahedron 2000, 56, 249. (c) Ankenbauer, R. G.; Toyokuni, T.; Staley, A.;
Rinehart, K. L.; Cox, C. D. J. Bacteriol. 1988, 170, 5344.
7420 J. Org. Chem. 2008, 73, 7420–7423
10.1021/jo801294p CCC: $40.75 2008 American Chemical Society
Published on Web 08/13/2008